Becton, Dickinson and Company (BDX)
| Market Cap | 55.36B |
| Revenue (ttm) | 21.84B |
| Net Income (ttm) | 1.68B |
| Shares Out | 285.42M |
| EPS (ttm) | 5.82 |
| PE Ratio | 33.33 |
| Forward PE | 12.98 |
| Dividend | $4.20 (2.17%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 1,784,740 |
| Open | 193.72 |
| Previous Close | 193.76 |
| Day's Range | 193.69 - 196.12 |
| 52-Week Range | 162.29 - 251.99 |
| Beta | 0.28 |
| Analysts | Buy |
| Price Target | 212.13 (+9.37%) |
| Earnings Date | Nov 6, 2025 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va... [Read more]
Financial Performance
In 2025, BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for BDX stock is "Buy." The 12-month stock price target is $212.13, which is an increase of 9.37% from the latest price.
News
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
FRANKLIN LAKES, N.J. , Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis FRANKLIN LAKES, N.J. , Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
FRANKLIN LAKES, N.J. , Nov. 24, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Surgiphor™ Surgic...
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huf...
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification
RANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Mark...
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH
FRANKLIN LAKES, N.J. , Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH He...
BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
FRANKLIN LAKES, N.J. , Nov. 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, introduces the PureWick™ Portable Collection System, a...
Becton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript
Becton, Dickinson and Company ( BDX) Q4 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Adam Reiffe Thomas Polen - President, CEO & Chairman Christopher DelOrefice - Executive VP...
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal
Becton Dickinson and Co (NYSE:BDX) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92.
Becton sees 2026 profit slightly above estimates on strong demand for drug delivery devices
Medical device maker Becton Dickinson on Thursday topped Wall Street estimates for fourth-quarter adjusted profit and forecast 2026 earnings slightly above expectations, supported by steady demand for...
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively FY25 revenue of $21.8 billion increased 8.2% as ...
BD Board Increases Dividend for 54th Consecutive Year
FRANKLIN LAKES, N.J. , Nov. 6, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.05 per common share, an increase of...
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
FRANKLIN LAKES, N.J. , Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient c...
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
FRANKLIN LAKES, N.J. , Nov. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Admin...
ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. The pattern of modest dividend increases continues, with o...
Best Dividend Aristocrats For November 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW...
Best Dividend Kings: October 2025
Dividend Kings are underperforming SPY in 2025, with a year-to-date return gap of 13.10%, but 12 Kings remain ahead of the index. Top performers include NFG, JNJ, ABBV, MO, FTS, ADM, NUE, GRC, NWN, PH...
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
FRANKLIN LAKES, N.J. , Oct. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV...
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand
For my followup on medtech stock Becton, Dickinson and Company, I'm reaffirming my prior buy rating, agreeing with the Wall St consensus today. Becton, Dickinson's growing and globally diverse portfol...
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
FRANKLIN LAKES, N.J. , Oct. 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care Platform, a new sca...
Fiduciary Management: A Few Holdings That We Find Compelling Over The Long Term
OneMain is a scale leader in nonprime personal lending. The macro backdrop has given us the opportunity to own OneMain at an attractive valuation. Becton, Dickinson's valuation is attractive given the...
Buy These 3 Dividend Aristocrats Now For Growing Passive Income
Chevron, Sherwin-Williams, and Becton, Dickinson and Company sport a market-doubling 2.5% dividend yield and trade at 6% to 21% discounts to our fair value estimates. CVX's combination of production g...